LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Total Revenue
354.433
222.61
433.287
63.639
40.718
Cost of Revenue
84.004
22.893
25.185
29.75
45.615
Gross Profit
270.429
199.717
408.102
33.889
-4.897
Operating Expenses
Research Development
686.694
555.73
492.864
54.185
9.024
Selling General and Administrative
3,576
3,643
6,513
1,842
1,197
Total Operating Expenses
4,367
4,260
7,008
1,895
1,211
Operating Income or Loss
-4,096
-4,060
-6,600
-1,861
-1,216
Interest Expense
-
-
0
6.015
2.25
Total Other Income/Expenses Net
-129.686
-98.616
-8.968
-62.196
-59.422
Income Before Tax
-4,226
-4,158
-6,609
-1,929
-1,277
Income from Continuing Operations
-4,226
-4,158
-6,609
-1,929
-1,277
Net Income
-4,108
-4,099
-6,599
-1,869
-1,215
Net Income available to common shareholders
-4,108
-4,099
-6,599
-1,869
-1,215
Basic EPS
-
-0.05
-0.09
-0.03
-0.03
Diluted EPS
-
-0.05
-0.09
-0.03
-0.03
Basic Average Shares
-
77,792
70,960
58,766
43,840
Diluted Average Shares
-
77,792
70,960
58,766
43,840
EBITDA
-
-3,999
-6,607
-1,922
-1,274